1B2Y | A:2-403 | STRUCTURE OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH THE CARBOHYDRATE INHIBITOR ACARBOSE |
1BHG | A:329-631; B:329-631 | HUMAN BETA-GLUCURONIDASE AT 2.6 A RESOLUTION |
1BSI | A:2-403 | HUMAN PANCREATIC ALPHA-AMYLASE FROM PICHIA PASTORIS, GLYCOSYLATED PROTEIN |
1C8Q | A:2-403 | STRUCTURE SOLUTION AND REFINEMENT OF THE RECOMBINANT HUMAN SALIVARY AMYLASE |
1CPU | A:2-403 | SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT |
1GUV | A:22-265,A:337-387 | STRUCTURE OF HUMAN CHITOTRIOSIDASE |
1HJV | A:22-259,A:330-383; B:22-259,B:330-383; C:22-259,C:330-383; D:22-259,D:330-383 | CRYSTAL STRUCTURE OF HCGP-39 IN COMPLEX WITH CHITIN TETRAMER |
1HJW | A:22-259,A:330-383; B:22-259,B:330-383 | CRYSTAL STRUCTURE OF HCGP-39 IN COMPLEX WITH CHITIN OCTAMER |
1HJX | A:22-259,A:330-383; B:22-259,B:330-382; D:22-259,D:330-382; C:22-259,C:330-382 | LIGAND-INDUCED SIGNALLING AND CONFORMATIONAL CHANGE OF THE 39 KD GLYCOPROTEIN FROM HUMAN ARTICULAR CHONDROCYTES |
1HKI | A:22-266,A:335-386 | CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH GLUCOALLOSAMIDIN B |
1HKJ | A:22-266,A:335-386 | CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH METHYLALLOSAMIDIN |
1HKK | A:22-266,A:335-385 | HIGH RESOULTION CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH ALLOSAMIDIN |
1HKM | A:22-266,A:335-386 | HIGH RESOLUTION CRYSTAL STRUCTURE OF HUMAN CHITINASE IN COMPLEX WITH DEMETHYLALLOSAMIDIN |
1HNY | A:2-403 | THE STRUCTURE OF HUMAN PANCREATIC ALPHA-AMYLASE AT 1.8 ANGSTROMS RESOLUTION AND COMPARISONS WITH RELATED ENZYMES |
1JXJ | A:2-403 | ROLE OF MOBILE LOOP IN THE MECHANISM OF HUMAN SALIVARY AMYLASE |
1JXK | A:2-398 | ROLE OF ETHE MOBILE LOOP IN THE MEHANISM OF HUMAN SALIVARY AMYLASE |
1KB3 | A:2-403 | THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R195A VARIANT OF HUMAN PANCREATIC ALPHA AMYLASE |
1KBB | A:2-403 | MECHANISTIC ANALYSES OF CATALYSIS IN HUMAN PANCREATIC ALPHA-AMYLASE: DETAILED KINETIC AND STRUCTURAL STUDIES OF MUTANTS OF THREE CONSERVED CARBOXYLIC ACIDS |
1KBK | A:2-403 | MECHANISTIC ANALYSES OF CATALYSIS IN HUMAN PANCREATIC ALPHA-AMYLASE: DETAILED KINETIC AND STRUCTURAL STUDIES OF MUTANTS OF THREE CONSERVED CARBOXYLIC ACIDS |
1KGU | A:2-403 | THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R337A VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE |
1KGW | A:2-403 | THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R337Q VARIANT OF HUMAN PANCREATIC ALPHA-MYLASE |
1KGX | A:2-403 | THREE DIMENSIONAL STRUCTURE ANALYSIS OF THE R195Q VARIANT OF HUMAN PANCREATIC ALPHA AMYLASE |
1LG1 | A:22-265,A:337-386 | CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE IN COMPLEX WITH CHITOBIOSE |
1LG2 | A:22-265,A:337-386 | CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE IN COMPLEX WITH ETHYLENE GLYCOL |
1LQ0 | A:22-266,A:335-386 | CRYSTAL STRUCTURE OF HUMAN CHITOTRIOSIDASE AT 2.2 ANGSTROM RESOLUTION |
1MFU | A:2-398 | PROBING THE ROLE OF A MOBILE LOOP IN HUMAN SALIVARY AMYLASE: STRUCTURAL STUDIES ON THE LOOP-DELETED MUTANT |
1MFV | A:2-403 | PROBING THE ROLE OF A MOBILE LOOP IN HUMAN SLAIVARY AMYLASE: STRUCTURAL STUDIES ON THE LOOP-DELETED ENZYME |
1NM9 | A:2-403 | CRYSTAL STRUCTURE OF RECOMBINANT HUMAN SALIVARY AMYLASE MUTANT W58A |
1NOU | A:198-552; B:198-552 | NATIVE HUMAN LYSOSOMAL BETA-HEXOSAMINIDASE ISOFORM B |
1NOW | A:198-552; B:198-552 | HUMAN LYSOSOMAL BETA-HEXOSAMINIDASE ISOFORM B IN COMPLEX WITH (2R,3R, 4S,5R)-2-ACETAMIDO-3,4-DIHYDROXY-5-HYDROXYMETHYL-PIPERIDINIUM CHLORIDE (GALNAC-ISOFAGOMINE) |
1NP0 | A:198-552; B:198-552 | HUMAN LYSOSOMAL BETA-HEXOSAMINIDASE ISOFORM B IN COMPLEX WITH INTERMEDIATE ANALOGUE NAG-THIAZOLINE |
1NWR | A:22-259,A:330-383; B:22-259,B:330-383; C:22-259,C:330-383; D:22-259,D:330-383 | CRYSTAL STRUCTURE OF HUMAN CARTILAGE GP39 (HC-GP39) |
1NWS | A:22-259,A:330-383; B:22-259,B:330-383; C:22-259,C:330-383; D:22-259,D:330-383 | CRYSTAL STRUCTURE OF HUMAN CARTILAGE GP39 (HC-GP39) IN COMPLEX WITH CHITOBIOSE |
1NWT | B:22-259,B:330-383; C:22-259,C:330-383; D:22-259,D:330-383; A:22-259,A:330-382 | CRYSTAL STRUCTURE OF HUMAN CARTILAGE GP39 (HC-GP39) IN COMPLEX WITH CHITOPENTAOSE |
1NWU | A:22-259,A:330-383; B:22-259,B:330-383; C:22-259,C:330-383; D:22-259,D:330-383 | CRYSTAL STRUCTURE OF HUMAN CARTILAGE GP39 (HC-GP39) IN COMPLEX WITH CHITOTETRAOSE |
1O7A | A:198-552; B:198-552; C:198-552; D:198-552; E:198-552; F:198-552 | HUMAN BETA-HEXOSAMINIDASE B |
1Q4N | X:2-403 | STRUCTURAL STUDIES OF PHE256TRP OF HUMAN SALIVARY ALPHA-AMYLASE: IMPLICATIONS FOR THE ROLE OF A CONSERVED WATER MOLECULE AND ITS ASSOCIATED CHAIN IN ENZYME ACTIVITY |
1SMD | A:2-403 | HUMAN SALIVARY AMYLASE |
1U2Y | A:2-403 | IN SITU EXTENSION AS AN APPROACH FOR IDENTIFYING NOVEL ALPHA-AMYLASE INHIBITORS, STRUCTURE CONTAINING D-GLUCONHYDROXIMO-1,5-LACTAM |
1U30 | A:2-403 | IN SITU EXTENSION AS AN APPROACH FOR IDENTIFYING NOVEL ALPHA-AMYLASE INHIBITORS, STRUCTURE CONTAINING MALTOSYL-ALPHA (1,4)-D-GLUCONHYDROXIMO-1,5-LACTAM |
1U33 | A:2-403 | IN SITU EXTENSION AS AN APPROACH FOR IDENTIFYING NOVEL ALPHA-AMYLASE INHIBITORS |
1WAW | A:22-265,A:337-389 | SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR ARGADIN AGAINST HUMAN CHITINASE |
1WB0 | A:22-265,A:339-388 | SPECIFICITY AND AFFINITY OF NATURAL PRODUCT CYCLOPENTAPEPTIDE INHIBITOR ARGIFIN AGAINST HUMAN CHITINASE |
1XCW | A:2-403 | ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS |
1XCX | A:2-403 | ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS |
1XD0 | A:2-403 | ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS |
1XD1 | A:2-403 | ACARBOSE REARRANGEMENT MECHANISM IMPLIED BY THE KINETIC AND STRUCTURAL ANALYSIS OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH ANALOGUES AND THEIR ELONGATED COUNTERPARTS |
1XGZ | A:2-403 | STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE |
1XH0 | A:2-403 | STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH ACARBOSE |
1XH1 | A:2-403 | STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH CHLORIDE |
1XH2 | A:2-403 | STRUCTURE OF THE N298S VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH CHLORIDE AND ACARBOSE |
1XV8 | A:2-403; B:2-403 | CRYSTAL STRUCTURE OF HUMAN SALIVARY ALPHA-AMYLASE DIMER |
1Y7V | A:5-30,A:78-431; B:5-30,B:78-431 | X-RAY STRUCTURE OF HUMAN ACID-BETA-GLUCOSIDASE COVALENTLY BOUND TO CONDURITOL B EPOXIDE |
1Z32 | X:2-403 | STRUCTURE-FUNCTION RELATIONSHIPS IN HUMAN SALIVARY ALPHA-AMYLASE: ROLE OF AROMATIC RESIDUES |
2CPU | A:2-403 | SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT |
2E9L | A:1-466 | CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NEUTRAL BETA-GLYCOSYLCERAMIDASE (KLOTHO-RELATED PROTE:KLRP) COMPLEX WITH GLUCOSE AND FATTY ACIDS |
2E9M | A:1-466 | CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC NEUTRAL BETA-GLYCOSYLCERAMIDASE (KLOTHO-RELATED PROTE:KLRP) COMPLEX WITH GALACTOSE AND FATTY ACIDS |
2F61 | A:5-30,A:78-431; B:5-30,B:78-431 | CRYSTAL STRUCTURE OF PARTIALLY DEGLYCOSYLATED ACID BETA-GLUCOSIDASE |
2GJX | C:198-552; B:198-552; F:198-552; G:198-552; A:165-528; D:165-528; E:165-528; H:165-528 | CRYSTALLOGRAPHIC STRUCTURE OF HUMAN BETA-HEXOSAMINIDASE A |
2GK1 | B:198-552; F:198-552; H:198-552; D:198-552; A:165-528; C:165-528; E:165-528; G:165-528 | X-RAY CRYSTAL STRUCTURE OF NGT-BOUND HEXA |
2J25 | A:5-30,A:78-431; B:5-30,B:78-431 | PARTIALLY DEGLYCOSYLATED GLUCOCERAMIDASE |
2JFE | X:3-461 | THE CRYSTAL STRUCTURE OF HUMAN CYTOSOLIC BETA-GLUCOSIDASE |
2NSX | A:5-30,A:78-431; B:5-30,B:78-431; C:5-30,C:78-431; D:5-30,D:78-431 | STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH PHARMACOLOGICAL CHAPERONE PROVIDES INSIGHT INTO GAUCHER DISEASE |
2NT0 | A:5-30,A:78-431; B:5-30,B:78-431; C:5-30,C:78-431; D:5-30,D:78-431 | ACID-BETA-GLUCOSIDASE LOW PH, GLYCEROL BOUND |
2NT1 | A:5-30,A:78-431; B:5-30,B:78-431; C:5-30,C:78-431; D:5-30,D:78-431 | STRUCTURE OF ACID-BETA-GLUCOSIDASE AT NEUTRAL PH |
2QMK | A:2-403 | HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH NITRITE |
2QV4 | A:2-403 | HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH NITRITE AND ACARBOSE |
2V3D | A:5-27,A:78-431; B:5-30,B:78-431 | ACID-BETA-GLUCOSIDASE WITH N-BUTYL-DEOXYNOJIRIMYCIN |
2V3E | A:5-29,A:78-431; B:5-30,B:78-431 | ACID-BETA-GLUCOSIDASE WITH N-NONYL-DEOXYNOJIRIMYCIN |
2V3F | B:5-26,B:78-431; A:5-28,A:78-431 | ACID-BETA-GLUCOSIDASE PRODUCED IN CARROT |
2VT0 | A:5-26,A:78-431; B:5-26,B:78-431 | X-RAY STRUCTURE OF A CONJUGATE WITH CONDURITOL-BETA-EPOXIDE OF ACID-BETA-GLUCOSIDASE OVEREXPRESSED IN CULTURED PLANT CELLS |
2WCG | A:5-26,A:78-431; B:5-28,B:78-431 | X-RAY STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH N-OCTYL( CYCLIC GUANIDINE)-NOJIRIMYCIN IN THE ACTIVE SITE |
2WKL | A:5-30,A:78-431; B:5-31,B:78-431 | VELAGLUCERASE ALFA |
2ZOX | A:1-466 | CRYSTAL STRUCTURE OF THE COVALENT INTERMEDIATE OF HUMAN CYTOSOLIC BETA-GLUCOSIDASE |
3BAI | A:2-403 | HUMAN PANCREATIC ALPHA AMYLASE WITH BOUND NITRATE |
3BAJ | A:2-403 | HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH NITRATE AND ACARBOSE |
3BAK | A:2-403 | N298S MUTANT OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH NITRATE |
3BAW | A:2-403 | HUMAN PANCREATIC ALPHA-AMYLASE COMPLEXED WITH AZIDE |
3BAX | A:2-403 | N298S VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH AZIDE |
3BAY | A:2-403 | N298S VARIANT OF HUMAN PANCREATIC ALPHA-AMYLASE IN COMPLEX WITH NITRATE AND ACARBOSE |
3BLK | A:2-403 | ROLE OF AROMATIC RESIDUES IN STARCH BINDING |
3BLP | X:2-403 | ROLE OF AROMATIC RESIDUES IN HUMAN SALIVARY ALPHA-AMYLASE |
3CPU | A:2-403 | SUBSITE MAPPING OF THE ACTIVE SITE OF HUMAN PANCREATIC ALPHA-AMYLASE USING SUBSTRATES, THE PHARMACOLOGICAL INHIBITOR ACARBOSE, AND AN ACTIVE SITE VARIANT |
3DHP | A:2-403 | PROBING THE ROLE OF AROMATIC RESIDUES AT THE SECONDARY SACCHARIDE BINDING SITES OF HUMAN SALIVARY ALPHA-AMYLASE IN SUBSTRATE HYDROLYSIS AND BACTERIAL BINDING |
3FXY | A:22-265,A:337-400; C:22-265,C:337-400; D:22-265,D:337-400; B:22-265,B:337-400 | ACIDIC MAMMALIAN CHINASE, CATALYTIC DOMAIN |
3FY1 | A:22-265,A:337-398; B:22-265,B:337-394 | THE ACIDIC MAMMALIAN CHITINASE CATALYTIC DOMAIN IN COMPLEX WITH METHYLALLOSAMIDIN |
3GXD | A:5-30,A:78-431; B:5-30,B:78-431; C:5-30,C:78-431; D:5-30,D:78-431 | CRYSTAL STRUCTURE OF APO ACID-BETA-GLUCOSIDASE PH 4.5 |
3GXF | A:5-30,A:78-431; B:5-30,B:78-431; C:5-30,C:78-431; D:5-30,D:78-431 | CRYSTAL STRUCTURE OF ACID-BETA-GLUCOSIDASE WITH ISOFAGOMINE AT NEUTRAL PH |
3GXI | A:5-30,A:78-431; B:5-30,B:78-431; C:5-30,C:78-431; D:5-30,D:78-431 | CRYSTAL STRUCTURE OF ACID-BETA-GLUCOSIDASE AT PH 5.5 |
3GXM | A:5-30,A:78-431; B:5-30,B:78-431; C:5-30,C:78-431; D:5-30,D:78-431 | CRYSTAL STRUCTURE OF ACID-BETA-GLUCOSIDASE AT PH 4.5, PHOSPHATE CRYSTALLIZATION CONDITION |
3HN3 | A:329-631; B:329-631; D:329-631; E:329-631 | HUMAN BETA-GLUCURONIDASE AT 1.7 A RESOLUTION |
3IJ7 | A:2-403 | DIRECTED 'IN SITU' ELONGATION AS A STRATEGY TO CHARACTERIZE THE COVALENT GLYCOSYL-ENZYME CATALYTIC INTERMEDIATE OF HUMAN PANCREATIC A-AMYLASE |
3IJ8 | A:2-403 | DIRECTED 'IN SITU' ELONGATION AS A STRATEGY TO CHARACTERIZE THE COVALENT GLYCOSYL-ENZYME CATALYTIC INTERMEDIATE OF HUMAN PANCREATIC A-AMYLASE |
3IJ9 | A:2-403 | DIRECTED 'IN SITU' ELONGATION AS A STRATEGY TO CHARACTERIZE THE COVALENT GLYCOSYL-ENZYME CATALYTIC INTERMEDIATE OF HUMAN PANCREATIC A-AMYLASE |